{"nctId":"NCT03506347","briefTitle":"Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement","startDateStruct":{"date":"2018-09-24","type":"ACTUAL"},"conditions":["Arthropathy of Knee Joint"],"count":24,"armGroups":[{"label":"Vancomycin 15mg/kg IV","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Vancomycin"]},{"label":"Vancomycin 500mg Intraosseous","type":"EXPERIMENTAL","interventionNames":["Drug: Vancomycin"]}],"interventions":[{"name":"Vancomycin","otherNames":["Vancocin"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria\n\nPrimary Total Knee Arthroplasty for osteoarthritis Informed consent given\n\nExclusion Criteria\n\nCurrent or treatment with IV Vancomycin within preceding 7 days Previous hypersensitivity to vancomycin Significant cardiac or respiratory abnormality Patient has contraindications to IO vascular access using the EZ-IO","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Vancomycin Concentration in Fat","description":"Mean vancomycin concentration in fat measured in ug/g at surgical closure","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0","spread":"0.85"},{"groupId":"OG001","value":"40.5","spread":"8.08"}]}]}]},{"type":"PRIMARY","title":"Vancomycin Concentration in Bone","description":"Mean vancomycin concentration in bone measured in ug/g at surgical closure","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.3","spread":"0.77"},{"groupId":"OG001","value":"26.9","spread":"1.31"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":[]}}}